AI
XENT

Axiom Investors’s Intersect ENT, Inc XENT Stock Holding History

Axiom Investors’s Portfolio XENT Stock Details XENT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-28,330
Closed -$663K – 144
2015
Q3 		$663K Buy
+28,330
New +$782K 0.02% 117

Other funds holding XENT

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
RIM
RS Investment Management San Francisco, California $9.73B AUM 3.24% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
KIA
Kopp Investment Advisors Bloomington, Minnesota $54.4M AUM 14.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Axiom Investors's XENT Position: Q4 2015 in Review

Axiom Investors sold out of Intersect ENT, Inc (XENT) in Q4 2015, closing a stake of 28,330 shares — an estimated $663K sold.

Axiom Investors first reported a position in XENT in Q3 2015 and held it in 1 quarter. The position peaked at $663K in Q3 2015. 115 funds tracked by Wall St. Rank hold XENT as of Q4 2015.

  • Axiom Investors reported no remaining Intersect ENT, Inc position as of Q4 2015 after selling out during the quarter.
  • Axiom Investors sold 28,330 Intersect ENT, Inc shares in Q4 2015, an estimated $663K.
  • Axiom Investors first reported a position in Intersect ENT, Inc in Q3 2015 and held it in 1 quarter.
  • Axiom Investors's Intersect ENT, Inc position peaked at $663K in Q3 2015.
  • 115 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q4 2015.

Based on Axiom Investors's 13F filing for Q4 2015, filed 12 Feb 2016.